Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HUB GROUP, INC. (HUBG)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

HUBG Shareholder Alert: Hub Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Market reaction Comment Full text

MEGAN HOLDINGS LTD. (MGN)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

MGN Shareholder Alert: Megan Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Market reaction Comment Full text

PENTAIR PLC (PNR)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

PNR UPCOMING DEADLINE: Levi & Korsinsky Alerts Pentair plc Stockholders of Securities Class Action - Contact the Firm

Market reaction Comment Full text

PHOTRONICS INC (PLAB)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

PLAB Shareholder Alert: Photronics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Market reaction Comment Full text

PLANET FITNESS, INC. (PLNT)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

PLNT Investor Alert: Planet Fitness, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Market reaction Comment Full text

ZOOMINFO TECHNOLOGIES INC. (GTM)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

GTM Deadline Alert: Levi & Korsinsky Reminds ZoomInfo Technologies, Inc. (GTM) Investors of Securities Class Action Deadline on August 24, 2026

Market reaction Comment Full text

PEABODY ENERGY CORP (BTU)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

BTU Deadline Alert: Levi & Korsinsky Reminds Peabody Energy Corporation (BTU) Investors of Securities Class Action Deadline on August 24, 2026

Market reaction Comment Full text

CAPRICOR THERAPEUTICS, INC. (CAPR)

  • Business News
  • Aug. 12, 2026, 14:07 UTC
  • 1
  • 1 comments

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

Market reaction Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • Aug. 12, 2026, 14:06 UTC
  • 1
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001193125-26-346348 <b>Size:</b> 596 KB

Comment Full text

MORGAN STANLEY (MS)

  • SEC News
  • Aug. 12, 2026, 14:06 UTC
  • 1
  • 0 comments

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001839882-26-039626 <b>Size:</b> 340 KB

Comment Full text

EGAIN CORP (EGAN)

  • Business News
  • Aug. 12, 2026, 14:05 UTC
  • 1
  • 1 comments

Unigarant kiest voor eGain om kennisbeheer te moderniseren en zijn AI-strategie te ondersteunen

Market reaction Comment Full text

EGAIN CORP (EGAN)

  • Business News
  • Aug. 12, 2026, 14:05 UTC
  • 1
  • 1 comments

Unigarant elige eGain para modernizar la gestión del conocimiento e impulsar su estrategia de IA empresarial

Market reaction Comment Full text

EGAIN CORP (EGAN)

  • Business News
  • Aug. 12, 2026, 14:05 UTC
  • 1
  • 1 comments

Unigarant choisit eGain pour moderniser sa gestion des connaissances et soutenir sa stratégie d’IA d’entreprise

Market reaction Comment Full text

EGAIN CORP (EGAN)

  • Business News
  • Aug. 12, 2026, 14:05 UTC
  • 1
  • 1 comments

Unigarant sceglie eGain per modernizzare la gestione delle conoscenze e potenziare la propria strategia aziendale in materia di IA

Market reaction Comment Full text

EGAIN CORP (EGAN)

  • Business News
  • Aug. 12, 2026, 14:05 UTC
  • 1
  • 1 comments

Unigarant setzt zur Modernisierung seines Wissensmanagements und zur Unterstützung seiner unternehmensweiten KI-Strategie auf eGain

Market reaction Comment Full text
  • Previous
  • 300
  • 301
  • 302
  • 303
  • 304
  • Next

Search

News categories

  • Technical Exchange News(14270)
  • Event(6229)
  • SEC News(368494)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(226524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin